Hormone Therapy Not Linked to Lung Cancer in Postmenopausal Women

In subgroup analyses, lower risk was seen with cumulative dosage of 401mg or greater, or with therapy duration of 5 years or longer.

Related Keywords

Taipei ,T Ai Pei ,Taiwan ,United States ,American ,Chia Chen Wu ,Stephanie Faubion ,American Menopause Society ,National Defense Medical Center ,Healthday News ,North American Menopause Society ,